AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 96 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,550 | -25.3% | 41,801 | +19.6% | 0.09% | -44.6% |
| Q2 2023 | $576,124 | +133.8% | 34,959 | +29.9% | 0.17% | +112.7% |
| Q1 2023 | $246,431 | +18.2% | 26,903 | -7.6% | 0.08% | +14.5% |
| Q4 2022 | $208,428 | +65.4% | 29,110 | +15.9% | 0.07% | +11.3% |
| Q3 2022 | $126,000 | +293.8% | 25,109 | +91.6% | 0.06% | +210.0% |
| Q2 2022 | $32,000 | – | 13,103 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 985,210 | $10,345,000 | 6.10% |
| Broadfin Capital, LLC | 3,568,122 | $37,465,000 | 5.54% |
| JW Asset Management, LLC | 444,439 | $4,667,000 | 3.42% |
| ARMISTICE CAPITAL, LLC | 1,688,000 | $17,724,000 | 2.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,655,494 | $38,383,000 | 1.73% |
| FALCON POINT CAPITAL, LLC | 661,490 | $6,284,000 | 0.91% |
| KNOTT DAVID M | 158,555 | $1,665,000 | 0.71% |
| Perceptive Advisors | 3,098,010 | $32,530,000 | 0.62% |
| Sio Capital Management, LLC | 91,413 | $960,000 | 0.50% |
| HEARTLAND ADVISORS INC | 700,000 | $7,350,000 | 0.48% |